Abstract
1964 was an important year in the history of haemolytic disease of the newborn. It was then that Clarke in England and Freda in the U.S. published, almost simultaneously, that rhesus (D) immunisation due to pregnancy could be prevented by administering immunoglobulin preparations containing a high titre of anti-rhesus (D) antibodies to the mother. This was the beginning of the end of the battle against this disease, first described in 1892 by Ballantyne,and whose pathogenesis was exposed in 1941 by Levine.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Reerink-Brongers, E.E. (1982). The Supply of Anti-Rhesus (D) Immunoglobulin in the Netherlands. In: Sibinga, C.T.S., Das, P.C., Forfar, J.O. (eds) Paediatrics and Blood Transfusion. Developments in Hematology and Immunology, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7520-0_6
Download citation
DOI: https://doi.org/10.1007/978-94-009-7520-0_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7522-4
Online ISBN: 978-94-009-7520-0
eBook Packages: Springer Book Archive